A New Vaccine May Help Stop The Return Of Certain Colorectal Pancreatic Cancers

https://www.mobidoctor.eu/blog/a-new-vaccine-may-help-stop-the-return-of-certain-colorectal-pancreatic-cancers

Exercise Combined With Mindfulness Is Best For Mental Health, Researchers Say

https://www.mobidoctor.eu/blog/exercise-combined-with-mindfulness-is-best-for-mental-health

How Eczema Can Create Adverse Mental Health Symptoms

https://www.mobidoctor.eu/blog/how-eczema-can-create-adverse-mental-health-symptoms

Obesity Linked To Precursor To Multiple Myeloma Blood Cancer

https://www.mobidoctor.eu/blog/obesity-linked-to-precursor-to-multiple-myeloma-blood-cancer

Can hearing aids reduce dementia risk and help people live longer?

Hearing loss has been linked to increased dementia risk and higher overall mortality. In this episode, we examine whether hearing aids may reduce cognitive decline risk and how hearing impairment is assessed in Europe.

In this episode, we cover:

• What age-related hearing loss is (sensorineural hearing decline)

• The association between hearing loss and dementia risk

• Possible mechanisms: social isolation, cognitive load, brain atrophy

• Research on hearing aid use and cognitive outcomes

• Limitations of observational studies

• When formal audiology testing is recommended

• When memory symptoms require neurological evaluation

• Situations where remote-only assessment may not be appropriate

Doctors assess hearing changes, communication difficulty, cognitive symptoms, cardiovascular risk factors, and functional impact before advising on next steps. Hearing aids require formal hearing assessment and fitting by trained professionals. Persistent memory decline, personality change, or functional deterioration requires in-person medical evaluation.

This episode reflects how sensory and cognitive health concerns are reviewed within structured medical assessment in European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/how-hearing-aids-can-reduce-dementia-risk-and-help-people-live-longer

Can people under 65 lower dementia risk with improved diet and lifestyle?

Modifiable risk factors in midlife may influence future dementia risk. In this episode, we examine how diet, physical activity, cardiovascular health, and other lifestyle factors affect brain health in adults under 65 across Europe.

In this episode, we cover:

• What dementia is (progressive cognitive decline affecting daily function)

• Why midlife risk factors matter for long-term brain health

• The role of blood pressure, cholesterol, and diabetes control

• Evidence linking Mediterranean-style diets to cognitive outcomes

• The impact of exercise, sleep quality, and smoking cessation

• Mental health, social engagement, and cognitive stimulation

• When memory symptoms require formal medical assessment

• Situations where in-person neurological evaluation is necessary

Doctors assess cardiovascular profile, BMI, smoking status, alcohol intake, metabolic markers, family history, and cognitive symptoms before advising on risk reduction. Lifestyle changes support overall health but do not eliminate dementia risk. Persistent or worsening memory changes require structured clinical evaluation.

This episode reflects how cognitive risk and preventive health are reviewed within European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/people-under-65-may-lower-dementia-risk-with-improved-diet-and-lifestyle

A Massive Number Of Plastic Particles Are Found In Bottled Water. Are They Harmful To Health?

https://www.mobidoctor.eu/blog/a-massive-number-of-plastic-particles-are-found-in-bottled-water

Are Ozempic, Wegovy, and other GLP-1 receptor agonists linked to pancreatic cancer risk?

Recent studies have examined whether GLP-1 receptor agonists (GLP-1RAs), including semaglutide (Ozempic, Wegovy), increase pancreatic cancer risk. In this episode, we review the current evidence and how medication safety is assessed in Europe.

In this episode, we cover:

• What GLP-1 receptor agonists are and how they work

• Why pancreatic safety concerns were previously raised

• Findings from recent large observational studies

• The difference between association and causation

• Ongoing pharmacovigilance and regulatory monitoring in the EU

• Known side effects of GLP-1 medicines

• Who may not be suitable candidates for GLP-1 therapy

• Situations where prescription requests may be declined

Doctors assess diabetes status, BMI, personal and family history of pancreatitis or pancreatic disease, gallbladder history, kidney function, and concurrent medications before prescribing. GLP-1 medicines are not appropriate for everyone, and some patients require blood tests or in-person review prior to initiation.

This episode reflects how medication safety and metabolic treatment decisions are reviewed within European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/ozempic-wegovy-other-glp-1ra-drugs-not-linked-to-increased-pancreatic-cancer-risk-study-finds

Why Weight Loss Drugs Stop Working And How To Break Past The Ozempic Plateau

https://www.mobidoctor.eu/blog/why-weight-loss-drugs-stop-working-and-how-to-break-past-the-ozempic-plateau

Can testosterone replacement therapy correct and prevent anemia?

Testosterone replacement therapy (TRT) has been studied for its effect on haemoglobin levels in men with clinically confirmed hypogonadism. In this episode, we explain how testosterone influences red blood cell production and when treatment may be considered in Europe.

In this episode, we cover:

• What anemia is (low haemoglobin or reduced oxygen-carrying capacity)

• Common causes of anemia in adults

• How testosterone stimulates erythropoiesis (red blood cell production)

• Evidence linking TRT to increased haemoglobin levels

• The risk of excessive red blood cell elevation (polycythaemia)

• Required blood tests before and during TRT

• When anemia requires further investigation for underlying causes

• Situations where prescription requests may be declined

Doctors assess testosterone levels with confirmed laboratory testing, full blood count results, iron status, kidney function, and underlying health conditions before considering therapy. Testosterone is not appropriate for unexplained anemia without confirmed hormone deficiency. Some patients require in-person evaluation or referral for further diagnostic work-up.

This episode reflects how hormone therapy and blood disorders are reviewed within structured medical assessment in European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/testosterone-replacement-therapy-can-correct-and-prevent-anemia